The AiCella Insights platform introduces a manufacturing-aware RAG framework designed to unify fragmented data within the cell and gene therapy (CGT) sector. This specialized AI system addresses the limitations of generic large language models by grounding its responses in proprietary internal records, ensuring both factual accuracy and full audibility. The process involves standardizing multi-modal data, such as handwritten logs and electronic files, into a secure and searchable knowledge base.